One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Exploring the role of accessory biomarkers TMB, STK11, KEAP1, and KRAS in non-small-cell lung cancer: confused, but on a much higher level
doi : 10.1016/j.annonc.2023.02.013
Volume 34, Issue 4, April 2023, Pages 327-332
Liquid biopsy accelerates precision medicine
O. Amato1,2 , P. Aftimos 1 & M. Ignatiadis
doi : 10.1016/j.annonc.2023.02.004
Volume 34, Issue 4, April 2023, Pages 333-335
Is it time for a paradigm shift in early rectal cancer treatment?
J. H. W. de Wilt 1 & S. P. Bach
doi : 10.1016/j.annonc.2023.01.002
Volume 34, Issue 4, April 2023, Pages 336-338
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
L. E. Hendriks1 , K. M. Kerr 2 , J. Menis3 , T. S. Mok4 , U. Nestle 5,6 , A. Passaro 7 , S. Peters 8 , D. Planchard 9 , E. F. Smit 10,11 , B. J. Solomon12 , G. Veronesi 13,14 & M. Reck15 , on behalf of the ESMO Guidelines Committee
doi : 10.1016/j.annonc.2022.12.009
Volume 34, Issue 4, April 2023, Pages 339-357
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
L. E. Hendriks1 , K. M. Kerr 2 , J. Menis3 , T. S. Mok 4 , U. Nestle 5,6 , A. Passaro7 , S. Peters8 , D. Planchard9 , E. F. Smit 10,11 , B. J. Solomon12 , G. Veronesi 13,14 & M. Reck15 , on behalf of the ESMO Guidelines Committee
doi : 10.1016/j.annonc.2022.12.013
Volume 34, Issue 4, April 2023, Pages 358-376
Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC☆
T. S. K. Mok 1* , G. Lopes2 , B. C. Cho3 , D. M. Kowalski 4 , K. Kasahara 5 , Y.-L. Wu 6 , G. de Castro, Jr 7 , H. Z. Turna8 , R. Cristescu 9 , D. Aurora-Garg9 , A. Loboda 9 , J. Lunceford9 , J. Kobie 9 , M. Ayers9 , M. C. Pietanza 9 , B. Piperdi 9 & R. S. Herbst
doi : 10.1016/j.annonc.2023.01.011
Volume 34, Issue 4, April 2023, Pages 377-388
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study
A. Bayle1,2,3y, L. Belcaid1,4y, M. Aldea 5 , D. Vasseur 6 , F. Peyraud 7 , C. Nicotra1 , A. Geraud 1 , M. Sakkal1,5 , L. Seknazi 1 , L. Cerbone 5 , F. Blanc-Durand 5 , J. Hadoux5 , F. Mosele 5 , M. Tagliamento 5 , A. Bernard-Tessier 5 , B. Verret 2,5 , C. Smolenschi 1 , R. Clodion 1 , N. Auger6 , P. M. Romano 1 , A. Gazzah1 , M. N. Camus 1 , J. Micol 8 , O. Caron 9 , A. Hollebecque 1 , Y. Loriot 1 , B. Besse 2,5 , L. Lacroix6 , E. Rouleau 6 , S. Ponce1 , J. C. Soria 2,5 , F. Barlesi2,5 , F. Andre 2,5 & A. Italiano
doi : 10.1016/j.annonc.2023.01.008
Volume 34, Issue 4, April 2023, Pages 389-396
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S. J. Luen1,2 , G. Viale3 , S. Nik-Zainal 4 , P. Savas1,2 , R. Kammler 5 , P. Dell’Orto6 , O. Biasi7 , A. Degasperi 4 , L. C. Brown 1,2 , I. Láng 8 , G. MacGrogan9 , C. Tondini 10 , M. Bellet 11 , F. Villa 12 , A. Bernardo 13 , E. Ciruelos 14 , P. Karlsson15 , P. Neven16 , M. Climent 17 , B. Müller18 , W. Jochum 19,20 , H. Bonnefoi21,22 , S. Martino23 , N. E. Davidson 24 , C. Geyer 25 , S. K. Chia 26 , J. N. Ingle27 , R. Coleman 28 , C. Solbach29 , B. Thürlimann 20,30 , M. Colleoni 31 , A. S. Coates 32 , A. Goldhirsch 33y, G. F. Fleming34 , P. A. Francis 1,2 , T. P. Speed35 , M. M. Regan 36 & S. Loi
doi : 10.1016/j.annonc.2023.01.009
Volume 34, Issue 4, April 2023, Pages 397-409
European cancer mortality predictions for the year 2023 with focus on lung cancer
M. Malvezzi1 , C. Santucci 1 , P. Boffetta2,3 , G. Collatuzzo3 , F. Levi 4 , C. La Vecchia 1* & E. Negri
doi : 10.1016/j.annonc.2023.01.010
Volume 34, Issue 4, April 2023, Pages 410-419
Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials☆
J. M. Versluis 1 , A. M. Menzies 2,3,4 , K. Sikorska5 , E. A. Rozeman1 , R. P. M. Saw 2,3,6,7 , W. J. van Houdt 8 , H. Eriksson9,10 , W. M. C. Klop 11 , S. Ch’ng 2,6,7 , J. V. van Thienen1 , H. Mallo1 , M. Gonzalez2 , A. Torres Acosta 5 , L. G. Grijpink-Ongering 5 , A. van der Wal 5 , A. Bruining 12 , B. A. van de Wiel 13 , R. A. Scolyer 2,3,14,15 , J. B. A. G. Haanen 1,16 , T. N. Schumacher 17,18 , A. C. J. van Akkooi2,3,7 , G. V. Long 2,3,4,15 & C. U. Blank
doi : 10.1016/j.annonc.2023.01.004
Volume 34, Issue 4, April 2023, Pages 420-430
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit
S. F. Oosting 1* , J. Barriuso 2 , A. Bottomley 3 , M. Galotti4 , B. Gyawali 5,6,7 , B. Kiesewetter 8 , N. J. Latino 4 , F. Martinelli 3 , M. Pe3 , G. Pentheroudakis 4 , F. Roitberg9,10 , H. Vachon 3 , E. G. E. de Vries1 , M. Piccart 11z & N. I. Cherny12z, on behalf of the ESMO-MCBS Working Group and Extended Working Group
doi : 10.1016/j.annonc.2022.12.004
Volume 34, Issue 4, April 2023, Pages 431-439
The role of chemoradiotherapy in organ preservation for rectal cancer
L. Xie 1 , Q. Chen 2 & J. Zhu
doi : 10.1016/j.annonc.2022.12.010
Volume 34, Issue 4, April 2023, Page 440
Reply to the Letter to the Editor ‘The role of chemoradiotherapy in organ preservation for rectal cancer’ by L. Xie, Q. Chen, and J. Zhu
X. Serra-Aracil1 * & C. Pericay
doi : 10.1016/j.annonc.2022.12.011
Volume 34, Issue 4, April 2023, Pages 440-442
The NEONAX study
M. W. Büchler & J. P. Neoptolemos
doi : 10.1016/j.annonc.2023.01.003
Volume 34, Issue 4, April 2023, Pages 442-443
Reply to the Letter to the Editor ‘The Neonax study’ by M. W. Büchler and J. Neoptolemos
. Seufferlein 1 *, W. Uhl 2 & T. J. Ettrich
doi : 10.1016/j.annonc.2023.01.005
Volume 34, Issue 4, April 2023, Pages 443-445
Authors’ reply—A sensitivity analysis of the RAPIDO clinical trial
E. A. Dijkstra1,y*, W. H. Zwart 1,y, H. Putter 2 , C. A. M. Marijnen 3,4,z, P. J. Nilsson 5,z, C. J. H. van de Velde 6,z, B. van Etten 7,z, G. A. P. Hospers1,z & B. Glimelius
doi : 10.1016/j.annonc.2022.12.012
Volume 34, Issue 4, April 2023, Pages 446-447
